Novo-middel viser vægttab hos børn mellem 6 og 12 år
- Words
- 18
- Chars
- 103
- AI summary
- Yes
Full story
Novo has conducted research on the effects of semaglutide in children. The study focused on children between the ages of 6 and 12. This specific substance is the active ingredient found in the weight loss medication Wegovy.
Novo har undersøgt effekten af semaglutid, der findes i vægttabsmidlet Wegovy, hos børn på 6 til 12 år.
Open article